Targeting pancreatic and prostate cancer with E1B19K-deleted oncolytic adenoviruses
dc.contributor.author | Hallden, G | en_US |
dc.date.accessioned | 2018-04-13T15:32:36Z | |
dc.date.issued | 2017-08 | en_US |
dc.date.submitted | 2018-01-16T16:46:56.270Z | |
dc.identifier.issn | 1043-0342 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/36345 | |
dc.format.extent | A6 - A6 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | HUMAN GENE THERAPY | en_US |
dc.title | Targeting pancreatic and prostate cancer with E1B19K-deleted oncolytic adenoviruses | en_US |
dc.type | Other | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407424800017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 8 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 28 | en_US |